Find a company, briefing, or insight.

41 resultsfor "Healthcare"

Insights

Insight

NZX healthcare comparison

Healthcare, retirement living, medical-device, and health-service companies compared on growth, margin, ROE, cash conversion, and leverage.

Companies

PHL · Healthcare / Aged care · 5 briefings

Promisia Healthcare

FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read

FPH · Healthcare / Medical devices · 7 briefings

Fisher & Paykel Healthcare

FPH capex nearly doubled to NZ$195.2m, compressing FCF conversion

RYM · Healthcare / Retirement living · 7 briefings

Ryman Healthcare

Free cash flow swings to +NZ$188m as EBITDAF nearly doubles

OCA · Healthcare / Retirement living · 7 briefings

Oceania Healthcare

OCA swung to PBT positive but capex jumped 82% to 40.4% of revenue

GXH · Healthcare / Pharmacy and health services · 7 briefings

Green Cross Health

Medical services-led NPAT growth of 27.5% on 4.2% revenue lift

TAH · Healthcare / Primary healthcare · 4 briefings

Third Age Health Services

PBT up 25.7% on ARC scale, full-year dividend reset to 8.0c

TRU · Healthcare / Medical diagnostics · 4 briefings

Truscreen Group

Revenue up 42% but missed $2.8m guidance as debtors swelled to $1.0m

ARV · Healthcare / Retirement living · 2 briefings

Arvida Group

Operating cash flow fell 33% as OCF/EBITDA dropped to 81% on lower ORA receipts

BLT · Healthcare / Biotechnology · 8 briefings

BLIS Technologies

Revenue up 16% but working-capital absorption turned operating cash flow

RAD · Healthcare / Aged care · 7 briefings

Radius Residential Care

PBT up 36.2% and cash conversion at 91.8% as capex more than doubled

RUA · Healthcare / Medicinal cannabis · 7 briefings

Rua Bioscience

Revenue grew to NZ$1.3m but losses persisted as borrowings quadrupled

SUM · Healthcare / Retirement living · 7 briefings

Summerset Group Holdings

PBT fell 32.2% on smaller revaluation gains; underlying profit up 13%

EBO · Healthcare / Healthcare distribution · 5 briefings

EBOS Group

Cash conversion collapsed to 15.4% as working capital absorbed $348m

PEB · Healthcare / Diagnostics · 4 briefings

Pacific Edge

Revenue down 45.8% as Medicare coverage loss halves US diagnostic income

Briefings

PHL · FY26

FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read

Full-year Cromwell consolidation and a sharp H2 earnings swing lift reported NPAT while net debt/EBITDAF falls from 11.1x to 5.8x.

FPH · FY26

FPH capex nearly doubled to NZ$195.2m, compressing FCF conversion

Operating cash flow rose to NZ$663.2m and cash built to NZ$461.1m, but capex hit 8.5% of revenue and FCF/NPAT fell to 95.3%.

RYM · FY26

Free cash flow swings to +NZ$188m as EBITDAF nearly doubles

Operating momentum is real but Ryman remains loss-making at the PBT line, and the FCF swing is partly capex-driven rather than purely earnings-led.

RYM · HY26

PBT collapsed 123% to a NZ$40.2m loss as debt fell NZ$928m

Maiden NZ$56.2m FCF and the balance sheet reset frame the upside, but a NZ$152.7m receivables release flatters the cash result.

FPH · HY26

Find a company, briefing, or insight.

Insights

NZX healthcare comparison

Companies

Promisia Healthcare

Fisher & Paykel Healthcare

Ryman Healthcare

Oceania Healthcare

Green Cross Health

Third Age Health Services

Truscreen Group

Arvida Group

BLIS Technologies

Radius Residential Care

Rua Bioscience

Summerset Group Holdings

EBOS Group

Pacific Edge

Briefings

FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read

FPH capex nearly doubled to NZ$195.2m, compressing FCF conversion

Free cash flow swings to +NZ$188m as EBITDAF nearly doubles

PBT collapsed 123% to a NZ$40.2m loss as debt fell NZ$928m

FPH PBT margin reached 26.1%, lifting profit 37.5% on 14.4% revenue growth

OCA swung to PBT positive but capex jumped 82% to 40.4% of revenue

EBITDAF tripled to $45.5m but NPAT loss widened to -$436.8m

Operating cash flow more than doubled to $548.6m as capex normalised

Capex jumped 354% to $132.4m, pushing FCF to -$22.1m

FPH PBT up 46.8% as capex normalisation swings FCF positive

PBT up 21.9% but NPAT fell 49.4% on a tax-rate flip

Underlying EBITDA up 2.7% but reported result swung to NZ$17.1m NPAT loss

PBT surged on a 25.6% revenue lift driven by prior-year acquisition

Capex cut 68% to manage 7.7x leverage; tax benefit inflated NPAT

Capex doubled to 34.3% of revenue, pre-lease FCF swung to NZ$127.5m negative

Dividend suspended as FCF stays $158.4m negative, PBT falls 34%

Revenue up 10.7% but PBT swung to a NZ$0.1m loss as costs outpaced growth

NPAT swung to NZ$35.2m but trade debtors expanded NZ$110.5m

PBT fell 73.7% as revenue growth failed to offset cost expansion

FY23 FCF collapsed to $12.5m as capex stepped up 53%

Net debt/EBITDA jumped to 6.9x as operating cash fell 33%

Working capital absorbed NZ$58.7m, draining operating cash to NZ$1.9m

NZ$281m working-capital build cut pre-lease FCF to NZ$51.8m as NPAT fell 31%

PBT fell 74.3% on lower Village revaluations as cash conversion slid

First full year of acquired aged-care lifts revenue to $19.0m

Reported NPAT jumped 63.8% but underlying profit grew only 13.6%